New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

Summary of associations between the colorectal tumor T cell response and sex. *A total of 99 patients (45 female; 54 male) with missing TILs/hpf data were excluded from the regression analysis. This ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

2024 — A study followed patients whose colorectal cancer was under control, but who had liver tumors that could not be surgically removed. All patients were ... Study Finds Regular Aspirin Use ...

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients. As someone who has overcome colorectal cancer ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

Between May 2005 and February 2009, a total of 45 colorectal tumors in 45 patients were resected by ESD at Tochigi Cancer Center, and the data for these cases were accumulated on a prospectively ...

Alarmed by the color and frequency of the blood in her stool, Mahon was referred to a GI doctor who initially thought she had an autoimmune disease. “Once I got the colonoscopy, she told me that she ...

A recent analysis from a randomized clinical trial conducted by researchers at the Dana-Farber Brigham Cancer Center ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...